Skip to main content
. Author manuscript; available in PMC: 2014 Jan 8.
Published in final edited form as: Ann Surg Oncol. 2011 Nov 3;19(4):10.1245/s10434-011-2125-1. doi: 10.1245/s10434-011-2125-1

Figure 5.

Figure 5

Survival curves between groups A and B in stages I (5a), II/III (5b) and IV (5c). Group A indicates the positive expression group in which ≥ 3 proteins among membranous type MUC13m, CDH17, LGALS4 and REG4 were expressed. Group B indicates the expression loss group in which ≤ 2 proteins among membranous type MUC13, CDH17, LGALS4 and REG4 were expressed.